3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Lung Neoplasms
3
Colorectal Neoplasms
3
Lymphoma
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Quality of Life
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Mixed Dementias
1
Mesothelioma, Malignant
1
Meningeal Carcinomatosis
1
Maxillary Sinus Neoplasms
1
Lymphoma, Follicular
1
Lewy Body Disease
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Doxorubicin
80
Ifosfamide
54
Radiotherapy
43
Filgrastim
41
Gemcitabine
38
Cyclophosphamide
34
Etoposide
26
Vincristine
24
Cisplatin
24
Docetaxel
23
pazopanib
21
Trabectedin
19
Carboplatin
17
pembrolizumab
15
Peripheral Blood Stem Cell Transplantation
14
eribulin
12
Mesna
12
Melphalan
12
Sorafenib
11
Sirolimus
11
Irinotecan
11
Granulocyte Colony-Stimulating Factor
11
Bevacizumab
11
Topotecan
10
Paclitaxel
10
Imatinib Mesylate
10
Chemotherapy, Adjuvant
10
pegfilgrastim
9
Temozolomide
9
Surgical Procedures, Operative
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sarcoma
×
Referral and Consultation
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts